These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 11081758

  • 21. Sequential analysis of anti-alpha Gal natural antibody-producing B cells in GalT knockout mice in cyclophosphamide-induced tolerance.
    Shimizu I, Tomita Y, Iwai T, Kajiwara T, Okano S, Nomoto K, Tominaga R.
    Scand J Immunol; 2006 Jun; 63(6):435-43. PubMed ID: 16764697
    [Abstract] [Full Text] [Related]

  • 22. Antibody-mediated accommodation of heart grafts expressing an incompatible carbohydrate antigen.
    Mohiuddin MM, Ogawa H, Yin DP, Shen J, Galili U.
    Transplantation; 2003 Feb 15; 75(3):258-62. PubMed ID: 12589143
    [Abstract] [Full Text] [Related]

  • 23. Mouse-to-rabbit xenotransplantation: a new small animal model of hyperacute rejection mediated by the classical complement pathway.
    Kerr SR, Dalmasso AP, Apasova EV, Chen SS, Kirschfink M, Matas AJ.
    Transplantation; 1999 Feb 15; 67(3):360-5. PubMed ID: 10030279
    [Abstract] [Full Text] [Related]

  • 24. Complement inhibition with an anti-C5 monoclonal antibody prevents hyperacute rejection in a xenograft heart transplantation model.
    Wang H, Rollins SA, Gao Z, Garcia B, Zhang Z, Xing J, Li L, Kellersmann R, Matis LA, Zhong R.
    Transplantation; 1999 Dec 15; 68(11):1643-51. PubMed ID: 10609940
    [Abstract] [Full Text] [Related]

  • 25. Failure to deplete anti-Galalpha1-3Gal antibodies after pig-to-baboon organ xenotransplantation by immunoaffinity columns containing multiple Galalpha1-3Gal oligosaccharides.
    Mañez R, Domenech N, Centeno A, Lopez-Pelaez E, Crespo F, Juffe A, Duthaler RO, Katopodis AG.
    Xenotransplantation; 2004 Sep 15; 11(5):408-15. PubMed ID: 15303977
    [Abstract] [Full Text] [Related]

  • 26. Comparison of Gal and non-Gal-mediated cardiac xenograft rejection.
    Tazelaar HD, Byrne GW, McGregor CG.
    Transplantation; 2011 May 15; 91(9):968-75. PubMed ID: 21403591
    [Abstract] [Full Text] [Related]

  • 27. Delayed rejection of porcine cartilage is averted by transgenic expression of alpha1,2-fucosyltransferase.
    Costa C, Brokaw JL, Wang Y, Fodor WL.
    FASEB J; 2003 Jan 15; 17(1):109-11. PubMed ID: 12475900
    [Abstract] [Full Text] [Related]

  • 28. Removal of anti-Galalpha1,3Gal xenoantibodies with an injectable polymer.
    Katopodis AG, Warner RG, Duthaler RO, Streiff MB, Bruelisauer A, Kretz O, Dorobek B, Persohn E, Andres H, Schweitzer A, Thoma G, Kinzy W, Quesniaux VF, Cozzi E, Davies HF, Mañez R, White D.
    J Clin Invest; 2002 Dec 15; 110(12):1869-77. PubMed ID: 12488437
    [Abstract] [Full Text] [Related]

  • 29. Use of lentiviral vectors to induce long-term tolerance to gal(+) heart grafts.
    Kearns-Jonker M, Fischer-Lougheed J, Shulkin I, Kleihauer A, Mitsuhashi N, Kohn DB, Weinberg K, D'Apice AJ, Starnes VA, Cramer DV.
    Transplantation; 2004 Jun 15; 77(11):1748-54. PubMed ID: 15201677
    [Abstract] [Full Text] [Related]

  • 30. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U.
    Transfus Apher Sci; 2006 Aug 15; 35(1):45-58. PubMed ID: 16905361
    [Abstract] [Full Text] [Related]

  • 31. The role of natural anti-Gal alpha 1-3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants.
    Lin SS, Kooyman DL, Daniels LJ, Daggett CW, Parker W, Lawson JH, Hoopes CW, Gullotto C, Li L, Birch P, Davis RD, Diamond LE, Logan JS, Platt JL.
    Transpl Immunol; 1997 Sep 15; 5(3):212-8. PubMed ID: 9402688
    [Abstract] [Full Text] [Related]

  • 32. Characteristics of α-Gal epitope, anti-Gal antibody, α1,3 galactosyltransferase and its clinical exploitation (Review).
    Huai G, Qi P, Yang H, Wang Y.
    Int J Mol Med; 2016 Jan 15; 37(1):11-20. PubMed ID: 26531137
    [Abstract] [Full Text] [Related]

  • 33. Importance of the Gal alpha1-3 Gal antigen in discordant islet xenotransplantation: immunosuppression, which inhibits porcine islet xenograft rejection in ordinary mice, is equally effective in Gal-knockout mice.
    Wennberg L, Song Z, Bennet W, Sandberg JO, Sundberg B, Thall A, Korsgren O.
    Transplantation; 2004 Apr 27; 77(8):1275-80. PubMed ID: 15114098
    [Abstract] [Full Text] [Related]

  • 34. Gal alpha (1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies.
    Sandrin MS, McKenzie IF.
    Immunol Rev; 1994 Oct 27; 141():169-90. PubMed ID: 7532618
    [Abstract] [Full Text] [Related]

  • 35. Hyperacute rejection of hDAF-transgenic pig organ xenografts in cynomolgus monkeys: influence of pre-existing anti-pig antibodies and prevention by the alpha GAL glycoconjugate GAS914.
    Lam TT, Hausen B, Boeke-Purkis K, Paniagua R, Lau M, Hook L, Berry G, Higgins J, Duthaler RO, Katopodis AG, Robbins R, Reitz B, Borie D, Schuurman HJ, Morris RE.
    Xenotransplantation; 2004 Nov 27; 11(6):517-24. PubMed ID: 15479461
    [Abstract] [Full Text] [Related]

  • 36. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons.
    Loveland BE, Milland J, Kyriakou P, Thorley BR, Christiansen D, Lanteri MB, Regensburg M, Duffield M, French AJ, Williams L, Baker L, Brandon MR, Xing PX, Kahn D, McKenzie IF.
    Xenotransplantation; 2004 Mar 27; 11(2):171-83. PubMed ID: 14962279
    [Abstract] [Full Text] [Related]

  • 37. Allogeneic sensitization is more effective than xenogeneic sensitization in eliciting Gal-mediated skin graft rejection.
    Gock H, Murray-Segal L, Salvaris E, Cowan P, D'Apice AJ.
    Transplantation; 2004 Mar 15; 77(5):751-3. PubMed ID: 15021840
    [Abstract] [Full Text] [Related]

  • 38. Mechanism of delayed rejection in transgenic pig-to-primate cardiac xenotransplantation.
    Chen RH, Kadner A, Mitchell RN, Adams DH.
    J Surg Res; 2000 May 15; 90(2):119-25. PubMed ID: 10792951
    [Abstract] [Full Text] [Related]

  • 39. Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal alpha 1,3Gal-mediated graft rejection.
    Ohdan H, Yang YG, Shimizu A, Swenson KG, Sykes M.
    J Clin Invest; 1999 Aug 15; 104(3):281-90. PubMed ID: 10430609
    [Abstract] [Full Text] [Related]

  • 40. The in vitro and in vivo effects of anti-galactose antibodies on endothelial cell activation and xenograft rejection.
    Xu H, Yin D, Naziruddin B, Chen L, Stark A, Wei Y, Lei Y, Shen J, Logan JS, Byrne GW, Chong AS.
    J Immunol; 2003 Feb 01; 170(3):1531-9. PubMed ID: 12538718
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.